MORNEAU MICHAEL 4
4 · Viking Therapeutics, Inc. · Filed Oct 31, 2019
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-10-31+2,500→ 2,500 totalExercise: $6.47From: 2020-10-31Exp: 2029-10-31→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on each anniversary of the grant date.